Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jérôme Galon"'
Autor:
Paolo A. Ascierto, Sanjiv S. Agarwala, Allison Betof Warner, Marc S. Ernstoff, Bernard A. Fox, Thomas F. Gajewski, Jérôme Galon, Claus Garbe, Brian R. Gastman, Jeffrey E. Gershenwald, Pawel Kalinski, Michelle Krogsgaard, Rom S. Leidner, Roger S. Lo, Alexander M. Menzies, Olivier Michielin, Poulikos I. Poulikakos, Jeffrey S. Weber, Corrado Caracò, Iman Osman, Igor Puzanov, Magdalena Thurin
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Outcomes for patients with melanoma have improved over the past decade with the clinical development and approval of immunotherapies targeting immune checkpoint receptors such as programmed death-1 (PD-1), programmed death ligand 1 (PD-L1) o
Externí odkaz:
https://doaj.org/article/06bb97ac823040b3bb11134f118a0c11
Autor:
Paolo A. Ascierto, Antonio Avallone, Nina Bhardwaj, Carlo Bifulco, Sergio Bracarda, Joshua D. Brody, Luigi Buonaguro, Sandra Demaria, Leisha A. Emens, Robert L. Ferris, Jérôme Galon, Samir N. Khleif, Christopher A. Klebanoff, Tamara Laskowski, Ignacio Melero, Chrystal M. Paulos, Sandro Pignata, Marco Ruella, Inge Marie Svane, Janis M. Taube, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-19 (2022)
Abstract Over the past decade, immunotherapy has become an increasingly fundamental modality in the treatment of cancer. The positive impact of immune checkpoint inhibition, especially anti-programmed death (PD)-1/PD-ligand (L)1 blockade, in patients
Externí odkaz:
https://doaj.org/article/c7c0a3307fce4f8da5d3d700a08bd2c5
Autor:
Paolo A. Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A. Emens, Robert Ferris, Silvia C. Formenti, Jerome Galon, Samir N. Khleif, Tomas Kirchhoff, Jennifer McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Janis M. Taube, John Timmerman, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-16 (2021)
Abstract Improved understanding of tumor immunology has enabled the development of therapies that harness the immune system and prevent immune escape. Numerous clinical trials and real-world experience has provided evidence of the potential for long-
Externí odkaz:
https://doaj.org/article/07442960a2f94c70a8eca356003aaba9
Autor:
Samir N. Khleif, Francesco M. Marincola, Jérôme Galon, Leisha A. Emens, Samuel C. Silverstein
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, 2012, 10 (1), pp.70. ⟨10.1186/1479-5876-10-70⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.70. ⟨10.1186/1479-5876-10-70⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.70. 〈10.1186/1479-5876-10-70〉
Journal of Translational Medicine, Vol 10, Iss 1, p 70 (2012)
Journal of Translational Medicine, 2012, 10 (1), pp.70. ⟨10.1186/1479-5876-10-70⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.70. ⟨10.1186/1479-5876-10-70⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.70. 〈10.1186/1479-5876-10-70〉
Journal of Translational Medicine, Vol 10, Iss 1, p 70 (2012)
The development of cancer has historically been attributed to genomic alterations of normal host cells. Accordingly, the aim of most traditional cancer therapies has been to destroy the transformed cells themselves. There is now widespread appreciati
Autor:
Jerome Galon, Alessandro Lugli, Carlo Bifulco, Franck Pages, Giuseppe Masucci, Francesco M. Marincola, Paolo A. Ascierto
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-8 (2017)
Abstract The predictive accuracy of the traditional staging system is based on disease progression as a tumour cell-autonomous process, but it fails to incorporate the effects of the host immune response. A precise analysis of the immune component of
Externí odkaz:
https://doaj.org/article/cac470a6a28944119796278e9d601a22
Autor:
Roger S. Lo, Bastian Schilling, Francesco M. Marincola, David F. Stroncek, Silvia C. Formenti, Nicola Mozzillo, Rolf Kiessling, Pedro Romero, Sara Tomei, Alistair J. Cochran, Carlo Bifulco, Sandra Demaria, Igor Puzanov, Thomas F. Gajewski, Gennaro Ciliberto, Ena Wang, Grant Mc Arthur, Paul Lorigan, Giorgio Parmiani, Claus Garbe, Hassane M. Zarour, Alessandro Testori, Michael Davies, Gerardo Botti, Soldano Ferrone, Giuseppe Masucci, Janis M. Taube, Magdalena Thurin, Martin C. Mihm, Giuseppe Palmieri, Barbara Seliger, Samir N. Khleif, Paolo A. Ascierto, Reinhard Dummer, Michael B. Atkins, Ignacio Melero, Jérôme Galon
Publikováno v:
Journal of translational medicine, vol 13, iss 1
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
Journal of Translational Medicine, vol. 13, pp. 374
Journal of translational medicine (Online) (2015). doi:10.1186/s12967-015-0736-1
info:cnr-pdr/source/autori:Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M,? Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Mc Arthur G, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola F, Thurin M/titolo:Future perspectives in melanoma?research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014/doi:10.1186%2Fs12967-015-0736-1/rivista:Journal of translational medicine (Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Journal of Translational Medicine
The fourth "Melanoma Bridge Meeting" took place in Naples, December 3-6th, 2014. The four topics discussed at this meeting were: Molecular and Immunological Advances, Combination Therapies, News in Immunotherapy, and Tumor Microenvironment and Biomar
Autor:
Iris D. Nagtegaal, Paul Waring, Michael I. Nishimura, Richard Palmqvist, Carlo Bifulco, Yutaka Kawakami, Christian H. Ottensmeier, Alessandro Lugli, Christoph Huber, Réjean Lapointe, Lotfi Chouchane, Noriyuki Sato, Helen K. Angell, Scott Kopetz, Kyogo Itoh, Michele Maio, Yili Wang, Bernard A. Fox, Thomas F. Gajewski, Christine Lagorce, Franck Pagès, Cedrik M. Britten, Ena Wang, Giuseppe Masucci, Patricia Shaw, Frank A. Sinicrope, Jill O'Donnell-Tormey, Fabiana Tatangelo, Andreas Lundqvist, Heinz Zwierzina, James P. Allison, Toshihiko Torigoe, P. Patel, Inti Zlobec, Blaise Clarke, Martin Asslaber, Corrado D'Arrigo, Shoichi Hazama, Martin C. Mihm, Harpreet Singh-Jasuja, Luigi Laghi, Anne Berger, Jérôme Galon, Samir N. Khleif, Paolo Delrio, Shilin N. Shukla, Gerardo Botti, Hartmann Arndt, Francesco M. Marincola, Leif Håkansson, Paolo A. Ascierto, Robert E. Hawkins, Bradly G. Wouters, Sacha Gnjatic, Graham Pawelec, Fabio Grizzi, Fernando Vidal-Vanaclocha, Shuji Ogino, Sebastian Kreiter, Kiyotaka Okuno, Peter Gibbs, Magdalena Thurin, Giorgio Trinchieri, Pamela S. Ohashi
Publikováno v:
Galon, Jérôme; Pagès, Franck; Marincola, Francesco M.; Angell, Helen K.; Thurin, Magdalena; Lugli, Alessandro; Zlobec, Inti; Berger, Anne; Bifulco, Carlo; Botti, Gerardo; Tatangelo, Fabiana; Britten, Cedrik M.; Kreiter, Sebastian; Chouchane, Lotfi; Delrio, Paolo; Arndt, Hartmann; Asslaber, Martin; Maio, Michele; Masucci, Giuseppe V.; Mihm, Martin; ... (2012). Cancer classification using the Immunoscore: a worldwide task force. Journal of translational medicine, 10, p. 205. London: BioMed Central 10.1186/1479-5876-10-205
Journal of Translational Medicine, 10. BioMed Central Ltd
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. 〈10.1186/1479-5876-10-205〉
Journal of Translational Medicine, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, Vol 10, Iss 1, p 205 (2012)
Journal of Translational Medicine, 10. BioMed Central Ltd
Journal of Translational Medicine
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. 〈10.1186/1479-5876-10-205〉
Journal of Translational Medicine, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩
Journal of Translational Medicine, Vol 10, Iss 1, p 205 (2012)
International audience; Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor staging (AJCC/UICC-TNM classification) s
Autor:
Franck Pagès, Bernard A. Fox, Thomas F. Gajewski, Giorgio Trinchieri, Francesco M. Marincola, Paolo A. Ascierto, Magdalena Thurin, Jérôme Galon
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. 〈10.1186/1479-5876-10-1〉
Journal of Translational Medicine, Vol 10, Iss 1, p 1 (2012)
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. 〈10.1186/1479-5876-10-1〉
Journal of Translational Medicine, Vol 10, Iss 1, p 1 (2012)
Journal of Translational Medicine, BioMed Central, 2012, 10 (1), pp.1. ⟨10.1186/1479-5876-10-1⟩
The outcome prediction in cancer is usually achieved by evaluating tissue samples obtained during surgical removal of the primary tumor focusing on their histopathological characteristics. Tumor staging (AJCC/UICC-TNM classification) summarizes data